Clinical Trial Update: Use of Mysimba in Patients With Weight Regain After Bariatric Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Mysimba for weight regain after bariatric surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bariatric Surgery Candidate
• Morbid Obesity

Drugs mentioned

• Mysimba (naltrexone/bupropion)

Snippet

Sponsor: Zuyderland Medisch Centrum | Conditions: Obesity, Morbid, Bariatric Surgery Candidate | Phase 4 | Status: UNKNOWN